A Teva spokesperson told Bloomberg that the company will continue to experience delays supplying Adderrall for the next 2-3 months. The ADHD treatment has been in short supply since at least August, according to Bloomberg's Ike Swetlitz.
https://www.tipranks.com/news/the-fly/teva-tells-bloomberg-it-sees-adderall-supply-issues-for-next-2-3-months?utm_source=advfn.com&utm_medium=referral
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Teva Pharmaceutical Indu... Charts.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Teva Pharmaceutical Indu... Charts.